We are live on ! Find out more
BVXVW

BiondVax Pharmaceuticals Ltd.
BVXVW

Delisted

BVXVW was delisted on the 13th of May, 2020.

Back to rankings

2 hedge funds and large institutions have $123K invested in BiondVax Pharmaceuticals Ltd. in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

16% less capital invested

Capital invested by funds: $146K → $123K (-$23K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$106K – – –
VIA
2
Vantage Investment Advisors
Pennsylvania
$17K – – –

BVXVW Hedge Fund Activity: Q4 2017 in Review

2 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q4 2017, worth a combined $123K — down 16% from $146K a quarter earlier.

Fund positioning in BVXVW was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $123K of BiondVax Pharmaceuticals Ltd. stock for Q4 2017, down 16% quarter-over-quarter.
  • 0 funds opened new BiondVax Pharmaceuticals Ltd. positions in Q4 2017 and 0 closed out.

Based on aggregated 13F filings for Q4 2017.